A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Feng Wang
The First Affiliated Hospital of Dalian Medical University
Principal Investigator - Fuxian Zhang
Beijing Shijitan Hospital. CMU
Principal Investigator - Haofu Wang
The Affiliated Hospital of Qingdao University
Principal Investigator - Jianjun Jiang
Qilu Hospital of Shandong University
Principal Investigator - Jichun Zhao
West China Hospital
Principal Investigator - Lan Zhang
RenJi Hospital
Principal Investigator - Pingfan Guo
First Affiliated Hospital of Fujian Medical University
Principal Investigator - Shaomang Lin
Second Affiliated Hospital of Guangzhou Medical University
Principal Investigator - Tong Qiao
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Principal Investigator - Wei Bi
The Second Hospital of Hebei Medical University
Principal Investigator - Wei Guo, Professor
Chinese PLA General Hospital
Principal Investigator - Weiguo Fu, Professor
Fudan University
Principal Investigator - Xiangchen Dai
Tianjin Medical University General Hospital
Principal Investigator - Xinwu Lu
Shanghai Ninth People's Hosptial , Shanghai JiaoTong University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Shijitan Hospital. Cmu
Beijing, Beijing Municipality, China
- Chinese- Pla General Hospital
Beijing, Beijing Municipality, China
- the First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
- the Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
- the Second Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
- Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
- the First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China
- Qilu Hospital of Shandong University
Jinan, Shandong, China
- the Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
- Renji Hospital Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
- Shanghai Ninth People'S Hosptial , Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, China
- Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality, China
- West China Hospital, Sichuan University
Chengdu, Sichuan, China
- General Hospital of Tianjin Medical University
Tianjin, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2016
- Primary completion
- 31 Oct 2018
- Completion
- 31 Aug 2020
- Last update posted
- 20 Jan 2021
- Registered enrollment
- 148
- Registry id
- NCT02720003
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.